OMV AG/ AT0000743059 /
5/30/2024 1:20:40 PM | Chg. -0.760 | Volume | Bid1:20:40 PM | Ask1:20:40 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
45.220EUR | -1.65% | - Turnover: - |
45.220Bid Size: - | 45.260Ask Size: - | 14.77 bill.EUR | 11.18% | 9.97 |
GlobeNewswire
3/26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
10/13/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
euro adhoc
7/28/2021
EANS-Tip Announcement: OMV Aktiengesellschaft / Half-year financial report according to art. 125 par...
euro adhoc
6/7/2021
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
euro adhoc
6/7/2021
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
euro adhoc
6/2/2021
EANS-Other capital market information: OMV Aktiengesellschaft / Acquisition and/or sale of treasury ...